| US5639724A
              (en)
            
            * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms | 
        
          | US6007840A
              (en)
            
            * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins | 
        
          | US5342625A
              (en)
            
            * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins | 
        
          | GB2222770B
              (en)
            
            * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins | 
        
          | US7081445B2
              (en)
            
            * | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms | 
        
          | US5294604A
              (en)
            
            * | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G | 
        
          | DK0448091T3
              (da)
            
            * | 1990-03-23 | 1999-05-03 | Yoshitomi Pharmaceutical | Farmaceutisk præparat indeholdende et i ringe grad vandopløseligt medikament | 
        
          | AU2140592A
              (en)
            
            * | 1991-05-17 | 1992-12-30 | Chiron Corporation | Inhibitor of nf-kappa b transcriptional activator and uses thereof | 
        
          | US6262022B1
              (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent | 
        
          | WO1993023010A1
              (en) | 1992-05-13 | 1993-11-25 | Sandoz Ltd. | Ophthalmic compositions containing a cyclosporin | 
        
          | DK0589843T3
              (da) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporinholdige farmaceutiske præparater | 
        
          | WO1994008538A1
              (en)
            
            * | 1992-10-22 | 1994-04-28 | Aktsionernoe Obschestvo 'olvik' | Medicinal ocular membrane and method of producing the same | 
        
          | SK283442B6
              (sk)
            
            
            † | 1993-04-20 | 2003-07-01 | Novartis Ag | Farmaceutický prípravok na orálne podanie | 
        
          | DE4322826A1
              (de)
            
            * | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmazeutisches Präparat | 
        
          | US20020099067A1
              (en)
            
            * | 1993-07-08 | 2002-07-25 | Ulrich Posanski | Pharmaceutical compositions for sparingly soluble therapeutic agents | 
        
          | PT649651E
              (pt)
            
            * | 1993-09-28 | 2001-03-30 | Scherer Gmbh R P | Preparacao de capsulas de gelatina macia | 
        
          | TW349870B
              (en)
            
            * | 1993-09-30 | 1999-01-11 | Janssen Pharmaceutica Nv | An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof | 
        
          | FR2711982B1
              (fr)
            
            * | 1993-11-02 | 1996-01-19 | Saint Gobain Vitrage | Canal de transfert et de conditionnement de verre en fusion. | 
        
          | JP4157969B2
              (ja)
            
            * | 1994-03-18 | 2008-10-01 | スパーナス  ファーマシューティカルズ  インコーポレイテッド | 乳化薬物送達システム | 
        
          | US5474979A
              (en)
            
            * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue | 
        
          | ATE218359T1
              (de) | 1994-11-03 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung | 
        
          | US5824638A
              (en)
            
            * | 1995-05-22 | 1998-10-20 | Shire Laboratories, Inc. | Oral insulin delivery | 
        
          | US5766629A
              (en)
            
            * | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations | 
        
          | US5962019A
              (en)
            
            * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations | 
        
          | US5827822A
              (en)
            
            * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles | 
        
          | US5834017A
              (en)
            
            * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations | 
        
          | EP0760237A1
              (en)
            
            * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions | 
        
          | DE19549852B4
              (de) | 1995-11-29 | 2009-06-04 | Novartis Ag | Cyclosporin enthaltende Präparate | 
        
          | CZ288631B6
              (cs)
            
            * | 1996-01-18 | 2001-08-15 | Galena, A. S. | Léčivé přípravky s obsahem cyklosporinu | 
        
          | US5858401A
              (en)
            
            * | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines | 
        
          | US5660858A
              (en)
            
            * | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions | 
        
          | US6465016B2
              (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles | 
        
          | US7255877B2
              (en)
            
            * | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles | 
        
          | CN1303985C
              (zh) | 1996-08-22 | 2007-03-14 | Rtp药品公司 | 含有水不溶性物质微粒的组合物及其制备法 | 
        
          | JP2000516256A
              (ja)
            
            * | 1997-01-30 | 2000-12-05 | ノバルティス  アクチエンゲゼルシャフト | サイクロスポリンaを含む無油医薬組成物 | 
        
          | DE19724605A1
              (de)
            
            * | 1997-06-11 | 1998-12-17 | Sueddeutsche Kalkstickstoff | Hydrophile, homogene Monogycerid-Formulierungen und Verfahren zu deren Herstellung | 
        
          | US6008191A
              (en)
            
            * | 1997-09-08 | 1999-12-28 | Panacea Biotec Limited | Pharmaceutical compositions containing cyclosporin | 
        
          | US6187747B1
              (en) | 1997-09-08 | 2001-02-13 | Panacea Biotech Limited | Pharmaceutical composition comprising cyclosporin | 
        
          | US6346511B1
              (en) | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin | 
        
          | IN188719B
              (en0)
            
            * | 1997-09-08 | 2002-11-02 | Panacea Biotec Ltd |  | 
        
          | DE69842121D1
              (de) | 1997-12-10 | 2011-03-17 | Cyclosporine Therapeutics Ltd | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen | 
        
          | DE19810655A1
              (de)
            
            * | 1998-03-12 | 1999-09-16 | Univ Eberhard Karls | Arzneimittel mit einem Gehalt an Ciclosporin | 
        
          | US6979456B1
              (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions | 
        
          | JP2002516267A
              (ja) | 1998-05-29 | 2002-06-04 | アールティーピー・ファーマ・インコーポレーテッド | 熱的に保護された微粒子組成物及びその最終蒸気滅菌 | 
        
          | EP0976394A1
              (en)
            
            * | 1998-07-30 | 2000-02-02 | Biosearch Italia S.p.A. | New injectable formulations | 
        
          | AU767154B2
              (en) | 1998-11-20 | 2003-10-30 | Skyepharma Canada Inc. | Dispersible phospholipid stabilized microparticles | 
        
          | JP2002531515A
              (ja) | 1998-12-11 | 2002-09-24 | ファーマソリューションズ・インコーポレイテッド | 水に難溶性の薬剤のための自己乳化組成物 | 
        
          | US6447806B1
              (en) | 1999-02-25 | 2002-09-10 | Novartis Ag | Pharmaceutical compositions comprised of stabilized peptide particles | 
        
          | US6057289A
              (en)
            
            * | 1999-04-30 | 2000-05-02 | Pharmasolutions, Inc. | Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system | 
        
          | JP2003509453A
              (ja)
            
            * | 1999-09-21 | 2003-03-11 | アールティーピー・ファーマ・インコーポレーテッド | 生物学的に活性な物質の、表面改質された粒状組成物 | 
        
          | US6720001B2
              (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients | 
        
          | AU2127400A
              (en)
            
            * | 1999-11-02 | 2001-05-14 | Cipla Limited | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof | 
        
          | US7732404B2
              (en)
            
            * | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin | 
        
          | GB0008785D0
              (en)
            
            * | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds | 
        
          | US8586094B2
              (en)
            
            * | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets | 
        
          | JP2004509146A
              (ja)
            
            * | 2000-09-20 | 2004-03-25 | スカイファーマ・カナダ・インコーポレーテッド | 安定化フィブレート微粒子 | 
        
          | CA2461730C
              (en)
            
            * | 2001-10-19 | 2012-05-15 | Isotechnika Inc. | Novel cyclosporin analog microemulsion preconcentrates | 
        
          | US6979672B2
              (en) | 2002-12-20 | 2005-12-27 | Polichem, S.A. | Cyclosporin-based pharmaceutical compositions | 
        
          | US20050059583A1
              (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components | 
        
          | US7151085B2
              (en)
            
            * | 2004-11-15 | 2006-12-19 | Allergan, Inc. | Therapeutic methods using cyclosporine components | 
        
          | US7135455B2
              (en)
            
            * | 2004-11-15 | 2006-11-14 | Allergan, Inc | Methods for the therapeutic use of cyclosporine components | 
        
          | EP1885342B8
              (en) | 2005-03-21 | 2016-06-22 | Teva Czech Industries s.r.o. | Crystallization inhibitor and its use in gelatin capsules | 
        
          | GB2451811A
              (en) | 2007-08-09 | 2009-02-18 | Ems Sa | Delivery composition for solubilising water-insoluble pharmaceutical active ingredients | 
        
          | PT2683406T
              (pt) | 2011-03-11 | 2019-07-08 | Beth Israel Deaconess Medical Ct Inc | Anticorpos anti-cd40 e utilização dos mesmos | 
        
          | JP6608917B2
              (ja) | 2014-09-26 | 2019-11-20 | ザ  ケマーズ  カンパニー  エフシー  リミテッド  ライアビリティ  カンパニー | スルホン化フッ素化、非フッ素化、又は部分フッ素化ウレタン | 
        
          | PT3307322T
              (pt) | 2015-09-04 | 2021-04-23 | Primatope Therapeutics Inc | Anticorpos anti-cp40 humanizados e as suas utilizações referência cruzada relativa às aplicações associadas |